ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001407.1|Bicereucin_1 # 1 # 456 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.314	BGC0001407.1|Bicereucin_1 	1	456	+	Loose	50	25.0238	vanY gene in vanA cluster	33.33	3002955	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanY; glycopeptide resistance gene cluster	ATGAAGGTGAAAAAAGTGAAAGAATGGATATTAGGTGGACGAAATCCAGCTAATTATATTTTATATAATGATTTTGATGTAAAATACTCAAACGAAGCTTCTAAAAACTTATATTCTCTAGAAAACCATGATGGATATGGAACAGCATTTCATTTTTTGGATAAAAATCTTTATCTAGGTAAGAAAGTTAAATTTGCAGGGATGGTAATGACAAAATTAGTTAAAGAATATACAGGTTTATGGATTAGGGCCGAGCAGGCAGGAGAGGATCTTTGGGAATTTTATCATATACATTCTGATCCTTTAAATGTAACAAATCAGTGGAAAGAGTGTAGTGTGATAGTAGATGTACCTAAAAGTATAGAAGCATTATCAGTAGGGGTGGTTTTAAAAGGTACTGGTCATATATGGTTTAGTTCAATGAGCGTTGAAATTGTAAATACAAAGAACGATTAA	MKVKKVKEWILGGRNPANYILYNDFDVKYSNEASKNLYSLENHDGYGTAFHFLDKNLYLGKKVKFAGMVMTKLVKEYTGLWIRAEQAGEDLWEFYHIHSDPLNVTNQWKECSVIVDVPKSIEALSVGVVLKGTGHIWFSSMSVEIVNTKND	MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR	49.83	gnl|BL_ORD_ID|4667|hsp_num:0	89			252	360	vancomycin; teicoplanin
BGC0001407.1|Bicereucin_3 # 1855 # 2610 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.336	BGC0001407.1|Bicereucin_3 	1855	2610	-	Loose	500	25.7942	OXA-807	27.45	3006007	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAACATGTCCTCGCATACGTTGGATCAAGGAACCCAGATTCAAAAACAAGGAAACATATAGAAAGGCTTCTTCAATCTTTATCTAAGAAATATAAAGAAGAAATTTCTCACGAGTTACTTACACCTAATGATATTCAATTATCACCATCGACGGGATGTAAAAATTGTTTTAAAACGGGAAAGTGTTCACTTGATAAAGTTCCAAAAGATGAAGGAGAACTTTTAAAACGGAAGTTGTTGGAGGCAGACTTTATTATTTTAGCTAGCCCCGTTTATTCACATAACGTTTCATCAGACATGAAAATGGTAATAGATAGACTATCATATTGGGCACACCTTTTTAAATTGGTAGGAAAGTCAGGCATTGTATTAGCAGCAGCTGAGAGTAATGGTGTAAATTTTGTAGCAGATTATTTAGAAAAAGTAGCATATGTATTAGGACTGCATGTAGTCGATAAAATTGGTTTAATGGGACATCAGGAATTAACGGATAATCAATTGGATTTTCTTACAGAAAGCATATATAACCATGTAATGGGAATTGAAAACCCATATGCTGATGAAAAGATAGAAGCAACGTTCCAAGCTTTAAAGCGATCATTTTTGGGGTATCCTCAAGACCATGCTGAATATGTATATTGGAAGGAAAGTGGAATGTTTGCTGCTTCTAGCTACCAAGAATATTTGGATAATGTATTAAGTCTTAGACAGGAACAAATAGCTAAAAAGATTAACGAATATTCTCATTGTTAA	MKHVLAYVGSRNPDSKTRKHIERLLQSLSKKYKEEISHELLTPNDIQLSPSTGCKNCFKTGKCSLDKVPKDEGELLKRKLLEADFIILASPVYSHNVSSDMKMVIDRLSYWAHLFKLVGKSGIVLAAAESNGVNFVADYLEKVAYVLGLHVVDKIGLMGHQELTDNQLDFLTESIYNHVMGIENPYADEKIEATFQALKRSFLGYPQDHAEYVYWKESGMFAASSYQEYLDNVLSLRQEQIAKKINEYSHC	MNKYFTCYVVASLFLSGCTVQHNLINKTQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTGWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVTFALNMEMRSEMPASIRNELLMKSLKQLNII	91.94	gnl|BL_ORD_ID|4042|hsp_num:0	5112			153	447	cloxacillin; oxacillin; cefalotin
BGC0001407.1|Bicereucin_5 # 3567 # 3809 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.300	BGC0001407.1|Bicereucin_5 	3567	3809	-	Loose	275	23.483	AAC(6')-Iq	34.62	3002560	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGAACATTGGGGATAAAATATTAAAGCATGCAATAATTTGTGATGAGACCAAAACGATTTCATGGCTAACAATAAATAATCATCATGACAAAAATTGGGGGATAGGTCCGATATCAGGAGAGTTTTATGATGGTTTAGCTGGTATATCACTGTTTTATCACTATCTATATAAAAAAAGTCACAACATAGAATATAAAAAATTAGGGATTACGCATTTAATATGGCAAAAGTTAAAGCATTAA	MNIGDKILKHAIICDETKTISWLTINNHHDKNWGIGPISGEFYDGLAGISLFYHYLYKKSHNIEYKKLGITHLIWQKLKH	MDYSICDIAESNELILEAAKILRKSFLDAGNESWVDIKKAIEEVEDCIEHPNLCLGICLDDKLIGWTGLRPMYDKTWELHPMVIKTEYQCRGIGKVLIKELEKRAKGRGIIGIALGTDDEYQKTSLSMIDINERNIFDEIGNIKNVTNHPYEFYKKCGYMIVGIIPNANGKRKPDIWMWKDIS	43.72	gnl|BL_ORD_ID|1223|hsp_num:0	1327			168	246	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0001407.1|Bicereucin_6 # 3827 # 5788 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.282	BGC0001407.1|Bicereucin_6 	3827	5788	-	Loose	2200	29.261	rpoB2	25.71	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGATTAAGAATGTGAACTTGAAAGAAGCAATTAAAGGGTTAACTGTAAGTGAGAGGTATGATACATTAAAAAACTCTGGGGTGAATTTAAATCTAAATATAAGCGCGTTAGAGGAATGGCGAAATAGAAAAAATTTATTAGCAGATGAAGACTTTACTGAAATGCTTACTGTTTTAGAGTATGATCCTGTATATTTTTCACACGCAATAAATGAGAATATTGAGGAGCATATAGATATTTACAAATCTAAAATTCTTGGAGAGAATTGGTTTATAGTCTTAAATGATATTTTGGATGAATTAGATAATCAAATTGAATATAAGAAAGAAATGAATCATAGTTACTTACTTAGACCATTCTTACTTTATGCAGAAAAAGAAATGAATAAATATATTGTGAATCGAAAAGACCCGTTACCAGTTGAGCCGCAAGTTATTCAACAAATAATGGAAAATTTAGCGAGTAAATTGTTTGCTGTATCAGTTAAAAGCTTTGTTTTGGAGTTAAATATTTCAAAGTTAAAGGATGAGCTTGCTGGAGAAACACCAGATGAAAGATTCCATTCATTTATCCGACTAATGGGTGAAAAAACTAGACTGGTTGATTTTTATAACGAGTATATTGTGCTTTCAAGGATTTTAGTAAATATAACAATACTGTTTGTTAATAATATTATTGAATTATTTGATAGATTACAAGAAAGCAAGTTAGACATTGTAAAAAATTTAGGTGTTCAAGAAGAGTTTAAAATTAGCAATATTTCTATTGGAGAAGGAGATACTCACCAACAAGGAAGATCTGTTATTGTATTAACTTTTGTTTCGGGAAAAAAGGTTGTGTATAAACCTAAGAATTTAAAGGTTGTTAGTGCATATAATTCTTTAATAGATTGGATTAATGATAAAAATAATATTTTAAAAATGCCTAGTTACAATACATTGATTTATGATGATTTTGTAATTGAAGAGTTTGTTGAAAAAAGAGATTGTAAATCTATAGAAGAAGTTAAAAAATATTATATTCGATATGGTCAAATATTAGGGATAATGTATATATTAAATGGTAATGATTTTCATATGGAAAATTTAATTGCGTCTGGTGAATACCCAATTATTGTGGATTTAGAAACGCTGTTACAAAATATAATTAACTTTAAAAATAAACCTTCGGCAGATTTAATCACTACGAAAAAAATGCTGAACTTAGTGAATAGTACTTTATTGTTACCTGAGAAACTTCTCAAAGGAGATATAACAGATGAAGGTATTGATATGAGTGCTTTAGCGGGGAAAGAGCAACATTTAGAAAGAAGGGAGTACCAACTTAAAAATCTGTTTACTGACAATATGGTCTTTGATCTTGAAAAAGTAAAAATTGAGGGAGCTAATAATATTCCTAAACTTAATGGGGAAAATGTTGATTATAGTACATATATAGATGAGATTGTAGTAGGTTTTGAGAACATATGTAATATATTTATTCAATATAGAGATGAATTATTACATAGTGGTATATTGGAAGAGTTTAAGGATGTAAAAGTTAGGCATGTACTGAGAAATACAGTTGTGTATGCGAAAATGTTAGCAAATACGTATCATCCAGACTATTTAAGAGATTCATTAAATCGTGAACAAGTGCTAGAAAATATTTGGGTACATCCTTTTGAAAGAAAAGAATTTATAAAAAGTGAAATGGAAGATATTCTAAATAATGATATACCAATATTCTTTAGTTACGCTTCTTCAAAAGACATCATTGACAGTAATGGTAAGCTACATAAAAATGTTATGGAGATAAGTGGTTATGAGAGATTCATTACTAAATTGAAAGAGTTGAATCCTTTTTTAATTGAGCAACAGGTTTCTGTAATAAATATAAAAACAGGTAGATATGGAGATAAGAAGTTTGAGAGAAATTATAGTGTGTGGGATGTAGCTACAGAAAAAAAGATAATCAGATAG	MIKNVNLKEAIKGLTVSERYDTLKNSGVNLNLNISALEEWRNRKNLLADEDFTEMLTVLEYDPVYFSHAINENIEEHIDIYKSKILGENWFIVLNDILDELDNQIEYKKEMNHSYLLRPFLLYAEKEMNKYIVNRKDPLPVEPQVIQQIMENLASKLFAVSVKSFVLELNISKLKDELAGETPDERFHSFIRLMGEKTRLVDFYNEYIVLSRILVNITILFVNNIIELFDRLQESKLDIVKNLGVQEEFKISNISIGEGDTHQQGRSVIVLTFVSGKKVVYKPKNLKVVSAYNSLIDWINDKNNILKMPSYNTLIYDDFVIEEFVEKRDCKSIEEVKKYYIRYGQILGIMYILNGNDFHMENLIASGEYPIIVDLETLLQNIINFKNKPSADLITTKKMLNLVNSTLLLPEKLLKGDITDEGIDMSALAGKEQHLERREYQLKNLFTDNMVFDLEKVKIEGANNIPKLNGENVDYSTYIDEIVVGFENICNIFIQYRDELLHSGILEEFKDVKVRHVLRNTVVYAKMLANTYHPDYLRDSLNREQVLENIWVHPFERKEFIKSEMEDILNNDIPIFFSYASSKDIIDSNGKLHKNVMEISGYERFITKLKELNPFLIEQQVSVINIKTGRYGDKKFERNYSVWDVATEKKIIR	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	56.20	gnl|BL_ORD_ID|2431|hsp_num:0	2831			519	723	rifampin; rifaximin; rifabutin; rifapentine
BGC0001407.1|Bicereucin_7 # 6002 # 6247 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.402	BGC0001407.1|Bicereucin_7 	6002	6247	-	Loose	600	22.3274	Bla1	33.33	3000090	protein homolog model	n/a	n/a	penam	antibiotic inactivation	class A Bacillus anthracis Bla beta-lactamase	ATGACAAACGAAGAAATCATTGTAGCATGGAAAAACCCGAAAGTAAGAGGTAAGAACATGCCATCTCACCCATCAGGAGTAGGATTCCAAGAATTATCAATTAATGAAATGGCGCAAGTAACAGGTGGAGCAGTTGAACAAAGAGCAACACCAGCAACACCAGCAACGCCTTGGCTTATTAAAGCATCATATGTTGTATCAGGCGCAGGTGTTTCATTTGTTGCAAGTTATATCACAGTTAACTAA	MTNEEIIVAWKNPKVRGKNMPSHPSGVGFQELSINEMAQVTGGAVEQRATPATPATPWLIKASYVVSGAGVSFVASYITVN	MIVLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTKWMKGNATGDKLIRAGVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAEVIVNAFR	26.21	gnl|BL_ORD_ID|1349|hsp_num:0	1338			9	126	
BGC0001407.1|Bicereucin_8 # 6283 # 6549 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.382	BGC0001407.1|Bicereucin_8 	6283	6549	-	Loose	500	25.409	sul3	31.58	3000413	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGACAAATGAAGAAATCATTGTAGCATGGAAAAATCCAAAAGTAAGAGGTAAGAACATGCCATCTCACCCATCAGGAGTAGGATTCCAAGAATTATCAATTAATGAAATGGCGCAAGTAACAGGTGGAGCAGTTGAACAAAGAGCAACACCAACATTAGCAACACCATTAACTCCACATACACCGTATGCAACATATGTTGTATCAGGTGGCGTAGTATCGGCAATTAGCGGTATTTTTTCAAACAATAAAACATGCCTAGGTTAA	MTNEEIIVAWKNPKVRGKNMPSHPSGVGFQELSINEMAQVTGGAVEQRATPTLATPLTPHTPYATYVVSGGVVSAISGIFSNNKTCLG	MSKIFGIVNITTDSFSDGGLYLDTDKAIEHALHLVEDGADVIDLGAASSNPDTTEVGVVEEIKRLKPVIKALKEKGISISVDTFKPEVQSFCIEQKVDFINDIQGFPYPEIYSGLAKSDCKLVLMHSVQRIGAATKVETNPEEVFTSMMEFFKERIAALVEAGVKRERIILDPGMGFFLGSNPETSILVLKRFPEIQEAFNLQVMIAVSRKSFLGKITGTDVKSRLAPTLAAEMYAYKKGADYLRTHDVKSLSDALKISKALG	33.46	gnl|BL_ORD_ID|358|hsp_num:0	396			639	753	sulfadiazine; sulfadimidine; sulfadoxine; sulfamethoxazole; sulfisoxazole; sulfacetamide; mafenide; sulfasalazine; sulfamethizole
BGC0001407.1|Bicereucin_9 # 6673 # 6918 # -1 # ID=1_9;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.390	BGC0001407.1|Bicereucin_9 	6673	6918	-	Loose	600	22.3274	Bla1	33.33	3000090	protein homolog model	n/a	n/a	penam	antibiotic inactivation	class A Bacillus anthracis Bla beta-lactamase	TTGACAAATGAAGAAATTATTGTAGCATGGAAAAATCCAAAAGTAAGAGGTAAGAACATGCCATCTCACCCATCAGGAGTAGGATTCCAAGAATTATCAATTAATGAAATGGCGCAAGTAACAGGTGGAGCAGTTGAACAAAGAGCAACACCAGCAACACCAGCAACGCCTTGGCTTATTAAAGCATCATATGTTGTATCAGGCGCAGGTGTTTCGTTTGTTGCAAGTTATATCACAGTTAATTAA	MTNEEIIVAWKNPKVRGKNMPSHPSGVGFQELSINEMAQVTGGAVEQRATPATPATPWLIKASYVVSGAGVSFVASYITVN	MIVLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTKWMKGNATGDKLIRAGVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAEVIVNAFR	26.21	gnl|BL_ORD_ID|1349|hsp_num:0	1338			9	126	
BGC0001407.1|Bicereucin_10 # 7121 # 9247 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.304	BGC0001407.1|Bicereucin_10 	7121	9247	-	Loose	1190	230.72	novA	28.34	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAAAAAAATAAGATATGTTGAACAAATGGAGCATAGTGAATGCGGATTATCGTGTATTGCTATGATATTAGATTTCTATAATCATTATGTTTCCTTGAGTGATTTAAGGAATGAATTTGGTTCGGTTAGTGTAGGGCATTCTTTTCAAGATTTACTTTATATAGCGCAAAAAAAGAAAATGAATGGAAAAGCCTATCAGGTAGATACATTAAGTTTAAAAGAGCTAAAGTTGCCATTGATCTTGCATTGGGAAGGGAAGCATTATGTTGTTTTAGAAAAAATAACTCAAAATAAATGGCATATTATTGACCCTTCAGGTGGTAGAAAAATTTTAAACTATAAAGAATTCAATAGTAGTTATTCTGGATATGCTTTACATATTTCTCCGAGTAATACATTTCTCGAGAAGAAGAAAGAGAAAAACAATATTTTTCTCAAGCATTTATTAAGTCAAAAGAAGTTACTAGCTGTTGTAATAATGGTGACTGTATTCATTCAAGTTATCGCCATAACAATCCCGTTACTAACTAAGTGGTATACAGATCAGGTCATAATGAAATCAGATTTAAAATTTTATTTTGCTACAGGTATAGGTATATTGACAATTTTTATCATGTATATGTTGATTTCTATCTTAAGAGGATGGACGATTTCAAAGCTCAATACGCGATTAGATTCTTCAATTATGAATAAATTTATGGAAGTTCTTTTCAGGTTGCCGTATCCACTTTTTGAGAATAAGTCTAATGGAGATCTATTATTTAGAGCAAATTCTAACACATTAATTAGGCAAATTCTTTCTACAACTATAGTTTCAGTTTTTATAGATTTGTTACTAGTAGTAACATTTACAGTAATTATGATGCAATATTCTCCATCTTTAACAATGTATATGCTCTTCATTTCTTTCTTATTAATTACTGTTTTAGTAATTAATGCGAGAGTTGTAAGAAAGTTATCTGATGATAATGTATCGAATCAAGTTAAAGTCCAATCAATTTTATTTGAAAATCTTAATGGAATTTCTGATATAAAAATGTTAGGACTAGAGAAGCAAATACATAAGGAATGGCAGAATAAGTTTAATAACCAGTTGAAGACAACAGAAAAATTAAATATTTGGACAAGTATTATCCAATCATTATCTAATTCAGTTCAATTTATTATACCGTTATTTATTTTGTGGTTAGGTAGTACTTTCATCTTTGAAGGGGAAATCACGATGGGGACGTTGCTAGCATTCAATTCTATTTCAGCATCTTTTATTACTCCAATCGTATCTTTGAGTCAAACATTTACAGAAATTGTTAAAGTTCGCTCGTATTTTCTGAGAATAATAGATGTGATGAAAACAAAAACAGAGTTTGAAGGATCTGAAAAAAATAAATTATCAGGTAAGATAAAAATGGAAAATGTTTCATTTAAATACAGTGTATTTGGTAAGGAAGTTCTCAAGAAAATCTCACTGTCAATTAATCCTGGTGAAACAGTTGCAATTGTTGGGGAGTCAGGTTCAGGAAAGAGTACACTTGCAAAATTGTTATTGGGATTTTATGTTCCGACTAATGGGGATATTTTATATGATGATACCTCTATCACAGATTATAACTTACCTTTTTTAAGGAAACAAATAGGAGCAATATTACAAGATTCTAAATTATTTAATCGCTCTATATATGAAAATTTAGCTATGATGCAGAAAGATGTAGATATAAATGACGTAGTTCAGGCTGCAGAGAAAGCAAATATTTTACGATATATAATGGAACTGCCAATGGGTTTTGAGACAATTGTCTCAGAAGCAGGGGGCAATTTATCTGGAGGACAACGTCAACGAATTCTTATAGCAAGGGCTTTAGTGAAATCTCCGCCAGTATTAATATTAGATGAGGCAACGAGTTCGCTAGATAATATTTCAGAAAAAATTATCGATCAAAATTTAGCGGAACTATCTTGTACACGGATAATCATTGCTCATAGATTAAGTACAATCGTGAATGCCGATAAGATAGTTGTACTGAATGATGGGGAAATTGTAGAACAAGGGACTCATCATGAATTACTTCAAAAAAGAGGGTACTACAATAAATTGTATAGCCTTCAAAATGAAGAAGTAAATAATTAA	MKKIRYVEQMEHSECGLSCIAMILDFYNHYVSLSDLRNEFGSVSVGHSFQDLLYIAQKKKMNGKAYQVDTLSLKELKLPLILHWEGKHYVVLEKITQNKWHIIDPSGGRKILNYKEFNSSYSGYALHISPSNTFLEKKKEKNNIFLKHLLSQKKLLAVVIMVTVFIQVIAITIPLLTKWYTDQVIMKSDLKFYFATGIGILTIFIMYMLISILRGWTISKLNTRLDSSIMNKFMEVLFRLPYPLFENKSNGDLLFRANSNTLIRQILSTTIVSVFIDLLLVVTFTVIMMQYSPSLTMYMLFISFLLITVLVINARVVRKLSDDNVSNQVKVQSILFENLNGISDIKMLGLEKQIHKEWQNKFNNQLKTTEKLNIWTSIIQSLSNSVQFIIPLFILWLGSTFIFEGEITMGTLLAFNSISASFITPIVSLSQTFTEIVKVRSYFLRIIDVMKTKTEFEGSEKNKLSGKIKMENVSFKYSVFGKEVLKKISLSINPGETVAIVGESGSGKSTLAKLLLGFYVPTNGDILYDDTSITDYNLPFLRKQIGAILQDSKLFNRSIYENLAMMQKDVDINDVVQAAEKANILRYIMELPMGFETIVSEAGGNLSGGQRQRILIARALVKSPPVLILDEATSSLDNISEKIIDQNLAELSCTRIIIAHRLSTIVNADKIVVLNDGEIVEQGTHHELLQKRGYYNKLYSLQNEEVNN	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	115.12	gnl|BL_ORD_ID|1112|hsp_num:0	1210			108	1779	novobiocin
